Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study
- PMID: 27755912
- DOI: 10.1148/radiol.2016132230
Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study
Abstract
Purpose To identify the variables and factors that affect the quantity and quality of nucleic acid yields from imaging-guided core needle biopsy. Materials and Methods This study was approved by the institutional review board and compliant with HIPAA. The authors prospectively obtained 232 biopsy specimens from 74 patients (177 ex vivo biopsy samples from surgically resected masses were obtained from 49 patients and 55 in vivo lung biopsy samples from computed tomographic [CT]-guided lung biopsies were obtained from 25 patients) and quantitatively measured DNA and RNA yields with respect to needle gauge, number of needle passes, and percentage of the needle core. RNA quality was also assessed. Significance of correlations among variables was assessed with analysis of variance followed by linear regression. Conditional probabilities were calculated for projected sample yields. Results The total nucleic acid yield increased with an increase in the number of needle passes or a decrease in needle gauge (two-way analysis of variance, P < .0001 for both). However, contrary to calculated differences in volume yields, the effect of needle gauge was markedly greater than the number of passes. For example, the use of an 18-gauge versus a 20-gauge biopsy needle resulted in a 4.8-5.7 times greater yield, whereas a double versus a single pass resulted in a 2.4-2.8 times greater yield for 18- versus 20-gauge needles, respectively. Ninety-eight of 184 samples (53%) had an RNA integrity number of at least 7 (out of a possible score of 10). Conclusion With regard to optimizing nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there should be a preference for using lower gauge needles over higher gauge needles with more passes. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 21, 2016.
Similar articles
-
Determining the Optimal Number of Core Needle Biopsy Passes for Molecular Diagnostics.Cardiovasc Intervent Radiol. 2018 Mar;41(3):489-495. doi: 10.1007/s00270-017-1861-4. Epub 2017 Dec 26. Cardiovasc Intervent Radiol. 2018. PMID: 29279975
-
Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle.Lung Cancer. 2010 Feb;67(2):166-9. doi: 10.1016/j.lungcan.2009.04.007. Epub 2009 May 17. Lung Cancer. 2010. PMID: 19450892
-
The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy.Cardiovasc Intervent Radiol. 2015 Dec;38(6):1595-602. doi: 10.1007/s00270-015-1097-0. Epub 2015 Apr 30. Cardiovasc Intervent Radiol. 2015. PMID: 25920917
-
High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions.Gastrointest Endosc. 2013 Jun;77(6):909-15. doi: 10.1016/j.gie.2013.01.001. Epub 2013 Feb 20. Gastrointest Endosc. 2013. PMID: 23433596
-
CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate.Radiology. 2003 Nov;229(2):475-81. doi: 10.1148/radiol.2291020499. Radiology. 2003. PMID: 14595149
Cited by
-
Preventive tract embolization with gelatin sponge slurry is safe and considerably reduces pneumothorax after CT-guided lung biopsy with use of large 16-18 coaxial needles.Br J Radiol. 2022 May 1;95(1133):20210869. doi: 10.1259/bjr.20210869. Epub 2022 Jan 5. Br J Radiol. 2022. PMID: 34986006 Free PMC article.
-
An analysis of research biopsy core variability from over 5000 prospectively collected core samples.NPJ Precis Oncol. 2021 Oct 27;5(1):94. doi: 10.1038/s41698-021-00234-8. NPJ Precis Oncol. 2021. PMID: 34707215 Free PMC article.
-
An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma.Oncologist. 2022 Oct 1;27(10):884-891. doi: 10.1093/oncolo/oyac139. Oncologist. 2022. PMID: 35925597 Free PMC article.
-
State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.J Clin Oncol. 2020 May 10;38(14):1633-1640. doi: 10.1200/JCO.19.02322. Epub 2020 Mar 5. J Clin Oncol. 2020. PMID: 32134701 Free PMC article.
-
Computed Tomography-Guided Transthoracic Needle Biopsy: Predictors for Diagnostic Failure and Tissue Adequacy for Molecular Testing.Front Med (Lausanne). 2021 May 19;8:650381. doi: 10.3389/fmed.2021.650381. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34095167 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical